版本:
中国

BRIEF-Atossa Genetics says second positive interim review on Phase 1 study of endoxifen may advance to final topical dosing level

May 10 Atossa Genetics Inc

* Atossa Genetics - second positive interim review on Phase 1 study of endoxifen from independent safety committee who concluded study may advance to final topical dosing level Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐